Correlates of Dependence and Beliefs About the Use of Hypnotics Among Zolpidem and Zopiclone Users

REFERENCES

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association.
   Google Scholar
• Andersen, A. B., & Frydenberg, M. (2011). Long-term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugs. Pharmacoepidemiology and Drug Safety, 20, 378–385. doi: 10.1002/pds.2104. Epub 2011 Jan 24.
   PubMed Web of Science ®Google Scholar
• Anthierens, S., Habraken, H., Petrovic, M., Deveugele, M., De Maeseneer, J., & Christiaens, T. (2007). First benzodiazepine prescriptions: qualitative study of patients’ perspectives. Canadian Family Physician, 53, 1200–1201.
   PubMedGoogle Scholar
• Ashton, C. H. (2002). Benzodiazepines: how they work & how to withdraw, The Ashton Manual. Retrieved from http://www. benzo.org.uk/manual/bzcha01.htm#4.
   Google Scholar
• Berman, A. H., Palmstierna, T., Källmén, H., & Bergman, H. (2007). The self-report Drug Use Disorders Identification Test-Extended (DUDIT-E): Reliability, validity, and motivational index. Journal of Substance Abuse Treatment, 32, 357–369.
   PubMed Web of Science ®Google Scholar
• Chen, V. C., Chen, H., Lin, T. Y., Chou, H. H., Lai, T. J., Ferri, C. P., & Gossop, M. (2008). Severity of heroin dependence in Taiwan: reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS). Addictive Behaviors, 33, 1590–1593.
   PubMed Web of Science ®Google Scholar
• Chien, C. P., & Cheng, T. A. (1985). Depression in Taiwan: epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi, 87, 335–338.
   PubMedGoogle Scholar
• Darcourt, G., Pringuey, D., Sallière, D., & Lavoisy J. (1999). The safety and tolerability of zolpidem–an update. Journal of Psychopharmacology, 13, 81–93.
   PubMed Web of Science ®Google Scholar
• de las Cuevas, C., Sanz, E. J., de la Fuente, J. A., Padilla, J., & Berenguer, J. C. (2000). The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction, 95, 245–250.
   PubMed Web of Science ®Google Scholar
• Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., & Johnson, M. W. (2005). Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of Clinical Psychiatry, 66, 31–41.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., & Weerts, E. M. (1997). Benzodiazepine self-administration in humans and laboratory animals: implications for problems of long-term use and abuse. Psychopharmacology (Berl), 134, 1–37.
   PubMed Web of Science ®Google Scholar
• Hajak, G., Muller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98, 1371–1378.
   PubMed Web of Science ®Google Scholar
• Holm, K. J., & Goa, K. L. (2000). Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs, 59, 865–889.
   PubMed Web of Science ®Google Scholar
• Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555–567.
   PubMed Web of Science ®Google Scholar
• Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14, 1–24.
   Web of Science ®Google Scholar
• Lee, K. H., & Berman, A. H. (2009). DUDIT-E Mandarin Chinese version. Retrieved from: http://eib.emcdda.europa.eu/html. cfm/index61869EN.html.
   Google Scholar
• Liappas, I. A., Malitas, P. N., Dimopoulos, N. P., Gitsa, O. E., Liappas, A. I., Nikolaou, Ch. K., & Christodoulou, G. N. (2003). Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. Journal of Psychopharmacology, 17, 131–135.
   PubMed Web of Science ®Google Scholar
• Manthey, L., Lohbeck, M., Giltay, E. J., van Veena, T., Zitman, F. G., & Penninx, B. W. (2012). Correlates of benzodiazepine dependence in the Netherlands study of depression and anxiety. Addiction, 107, 2173–2182. doi: 10.1111/j.1360-0443.2012.03975.x.
   PubMed Web of Science ®Google Scholar
• McLeod, P. J., Hung, A. R., Tamblyn, A. R., & Gayton, D. C. (1997). Defining inappropriate practice in prescribing for elderly people: A national consensus panel. Canadian Medical Association Journal, 156, 385–391.
   PubMed Web of Science ®Google Scholar
• Petrie, K. J., Weinman, J., Sharpe, N., & Buckley, J. (1996). Role of patients’ view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. British Medical Journal, 312, 1191–1194.
   PubMed Web of Science ®Google Scholar
• Phatak, H. M., & Thomas, J. 3rd. (2006). Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Annals of Pharmacotherapy, 40, 1737–1742.
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CSE-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
   Web of Science ®Google Scholar
• Rosenbaum, J. F. (2005). Attitudes toward benzodiazepines over the years. Journal of Clinical Psychiatry, 66 Suppl 2, 4–8.
   PubMedGoogle Scholar
• Sanger, D. J. (2004). The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs, 18(Suppl 1), 9–15.
   PubMed Web of Science ®Google Scholar
• Soyka, M., Bottlender, R., & Möller, H. J. (2000). Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry, 33, 138–141.
   PubMed Web of Science ®Google Scholar
• Su, T. P., Chen, T. J., Hwang, S. J., Chou, L. F., Fan, A. P., & Chen, Y. C. (2002). Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000. Zhonghua Yi Xue Za Zhi (Taipei), 65, 378–391.
   PubMedGoogle Scholar
• Terzano, M. G., Rossi, M., Palomba, V., Smerieri, A., & Parrino, L. (2003). New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Safety, 26, 261–282.
   PubMed Web of Science ®Google Scholar
• Tsai, J. H., Tang, T. C., Yeh, Y. C., Yang, Y. H., Tsang, H. Y., Wang, S. Y., & Chen, C. C. (2012). The Chinese version of the Severity of Dependence Scale as a screening tool for benzodiazepine dependence in Taiwan. Kaohsiung Journal of Medical Sciences, 28, 225–230. doi: 10.1016/j.kjms.2011.06.023.
   PubMedGoogle Scholar
• Tsutsui, S., & Zolpidem Study Group. (2001). A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. Journal of International Medical Research, 29, 163–177.
   PubMedGoogle Scholar
• Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64, 198–209.
   PubMed Web of Science ®Google Scholar
• Victorri-Vigneau, C., Feuillet, F., Wainstein, L., Grall-Bronnec, M., Pivette, J., Chaslerie, A., Jolliet, P. (2013). Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. European Journal of Clinical Pharmacology, 69, 1965–1972. doi: 10.1007/s00228-013-1557-x.
   PubMed Web of Science ®Google Scholar
• Vlainić, J., Jembrek, M. J., Vlainić, T., Strac D. Š., & Peričić, D. (2012). Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro. Acta pharmacologica Sinica, 33, 1469–1476. doi: 10.1038/aps.2012.89.
   PubMedGoogle Scholar
• Wolf, B., & Griffiths, R. R. (1991). Physical dependence on benzodiazepines: differences within the class. Drug and Alcohol Dependence, 29, 153–156.
   PubMedGoogle Scholar
• Zammit, G. (2009). Comparative tolerability of newer agents for insomnia. Drug and Alcohol Dependence, 32, 735–748.
   Google Scholar